Craneware plc (LON:CRW) Declares Dividend of GBX 15

Craneware plc (LON:CRW) declared a dividend on Tuesday, September 3rd, Upcoming.Co.Uk reports. Investors of record on Thursday, November 28th will be given a dividend of GBX 15 ($0.20) per share on Thursday, December 19th. This represents a dividend yield of 0.79%. The ex-dividend date of this dividend is Thursday, November 28th. This is a positive change from Craneware’s previous dividend of $11.00. The official announcement can be accessed at this link.

LON CRW opened at GBX 2,475 ($32.34) on Tuesday. Craneware has a 12 month low of GBX 1,615 ($21.10) and a 12 month high of GBX 3,197 ($41.77). The firm has a market capitalization of $651.46 million and a PE ratio of 45.00. The company’s 50 day simple moving average is GBX 2,328.72 and its 200 day simple moving average is GBX 2,345.68.

In related news, insider Keith Neilson acquired 4,527 shares of the stock in a transaction that occurred on Tuesday, September 17th. The shares were acquired at an average price of GBX 2,200 ($28.75) per share, for a total transaction of £99,594 ($130,137.20). Also, insider Will Whitehorn acquired 1,171 shares of the stock in a transaction that occurred on Thursday, November 14th. The shares were bought at an average price of GBX 2,550 ($33.32) per share, for a total transaction of £29,860.50 ($39,018.03).

A number of research analysts recently commented on the stock. Peel Hunt reiterated a “buy” rating and set a GBX 3,000 ($39.20) price objective on shares of Craneware in a research note on Tuesday, November 12th. Berenberg Bank reiterated a “buy” rating and set a GBX 2,500 ($32.67) price objective on shares of Craneware in a research note on Tuesday, September 3rd. Finally, Peel Hunt reiterated a “buy” rating and set a GBX 3,000 ($39.20) price objective on shares of Craneware in a research note on Tuesday, November 12th.

Craneware Company Profile

Craneware plc, together with its subsidiaries, develops, licenses, and supports computer software for the healthcare industry in the United States. The company offers patient engagement solutions, such as InSight Medical Necessity, a software-as-a-service (SaaS) solution that provides medical necessity validation for United States payers and advance beneficiary notice creation; and Trisus Patient Payment, which provides hospitals and health systems to modernize patient payment.

Read More: Correction

Dividend History for Craneware (LON:CRW)

Receive News & Ratings for Craneware Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Craneware and related companies with MarketBeat.com's FREE daily email newsletter.